                </a></li></ul></div><p><strong>Figure 1.  <span>Mouse plasma cell tumor tissue culture (PCT-TC) signature and survival analysis of human cancer patients</span></strong></p><a id="article1.body1.sec2.sec1.fig1.caption1.p1" name="article1.body1.sec2.sec1.fig1.caption1.p1"></a><p>27 RNA samples from 17 solid mouse plasma cell tumors and 10 tissue cultured mouse PCT-TC cell lines (including Baf3, a pre-B cell line) were used for the generation of PCT-TC signature. <strong>A.</strong> Mouse plasma cell tumor tissue culture signature. 1162 genes showing significant differences in expression between solid PCTs and tissue-cultured PCTs were selected by SAM analysis at the 99-percentile confidence level with a 0.001 FDR. <strong>Bâ€“D.</strong> Kaplan-Meier survival analysis of human cancer patients groups generated by unsupervised cluster analysis with mouse PCT-TC signature. <strong>B.</strong> Survival analysis of human mantle cell lymphoma patients group <a href="#pone.0000145-Rosenwald1">[12]</a> generated by unsupervised cluster analysis with 694 orthologs of the mouse PCT-TC signature genes. <strong>C.</strong> Survival analysis of human liver cancer patients <a href="#pone.0000145-Lee2">[13]</a> generated by unsupervised cluster analysis with 971 orthologs of the mouse PCT-TC signature genes. <strong>D.</strong> Survival analysis of human breast cancer patients <a href="#pone.0000145-vandeVijver1">[2]</a>, <a href="#pone.0000145-vantVeer1">[3]</a>, <a href="#pone.0000145-Chang1">[15]</a> generated by unsupervised cluster analysis with 470 orthologs of the mouse PCT-TC signature genes.</p>
<span>THISISTHEEND
